Literature DB >> 14627334

Hepatitis B virus gene in liver tissue promotes hepatocellular carcinoma development in chronic hepatitis C patients.

Shin-Ichi Fujioka1, Hiroyuki Shimomura, Yoshiaki Iwasaki, Kozo Fujio, Hiroshi Nakagawa, Yasuhiro Onishi, Shinjiro Takagi, Hideaki Taniguchi, Fumi Umeoka, Hirofumi Nakajima, Akio Moriya, Katsuyuki Nanba, Cheng-Yu Piao, Toshiyuki Shinji, Norio Koide, Yasush Shiratori.   

Abstract

The hepatitis B virus (HBV) gene has been detected in hepatocellular carcinoma (HCC) tissue negative for the hepatitis B surface antigen and positive for the hepatitis C virus (HCV) antibody, but the precise role of the HBV gene in hepatocarcinogenesis has yet to be clarified. We studied the HBV gene in liver tissue several years before the emergence of HCC. Eleven patients diagnosed with HCV-positive chronic liver disease and who developed HCC were assigned to group A. HBV DNA was detected in 8 of the 11 patients (73%). Twenty-five patients, who did not develop HCC, were selected as group B. Six of the group B patients were classified as DNA-positive (24%). The HBV DNA in liver tissue was found to be significantly related to HCC development (P < 0.01). Thus, the presence of the HBV gene in patients with chronic HCV associated-liver injury appears to promote hepatocarcinogenesis, although prospective studies are needed to confirm this result.

Entities:  

Mesh:

Year:  2003        PMID: 14627334     DOI: 10.1023/a:1026153800896

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  30 in total

1.  Hepatitis B virus DNA is frequently found in liver biopsy samples from hepatitis C virus-infected chronic hepatitis patients.

Authors:  K Koike; M Kobayashi; M Gondo; I Hayashi; T Osuga; S Takada
Journal:  J Med Virol       Date:  1998-04       Impact factor: 2.327

2.  State of HBV DNA in HBsAg-negative, anti-HCV-positive hepatocellular carcinoma: existence of HBV DNA possibly as nonintegrated form with analysis by Alu-HBV DNA PCR and conventional HBV PCR.

Authors:  S Kawai; O Yokosuka; F Imazeki; Y Maru; H Saisho
Journal:  J Med Virol       Date:  2001-08       Impact factor: 2.327

Review 3.  Histological grading and staging of chronic hepatitis.

Authors:  K Ishak; A Baptista; L Bianchi; F Callea; J De Groote; F Gudat; H Denk; V Desmet; G Korb; R N MacSween
Journal:  J Hepatol       Date:  1995-06       Impact factor: 25.083

4.  Stable expression and replication of hepatitis B virus genome in an integrated state in a human hepatoma cell line transfected with the cloned viral DNA.

Authors:  T Tsurimoto; A Fujiyama; K Matsubara
Journal:  Proc Natl Acad Sci U S A       Date:  1987-01       Impact factor: 11.205

5.  Hepatitis B virus DNA in peripheral-blood mononuclear cells in chronic hepatitis B after HBsAg clearance.

Authors:  A Mason; B Yoffe; C Noonan; M Mearns; C Campbell; A Kelley; R P Perrillo
Journal:  Hepatology       Date:  1992-07       Impact factor: 17.425

6.  Occult HBV infection in cryptogenic liver cirrhosis in an area with high prevalence of HBV infection.

Authors:  Henry Lik-Yuen Chan; Steven Woon-Choi Tsang; Nancy Wai-Yee Leung; Chi-Hang Tse; Yui Hui; John Siu-Lun Tam; Francis Ka-Leung Chan; Joseph Jao-Yiu Sung
Journal:  Am J Gastroenterol       Date:  2002-05       Impact factor: 10.864

7.  The hepatitis B virus persists for decades after patients' recovery from acute viral hepatitis despite active maintenance of a cytotoxic T-lymphocyte response.

Authors:  B Rehermann; C Ferrari; C Pasquinelli; F V Chisari
Journal:  Nat Med       Date:  1996-10       Impact factor: 53.440

8.  Selective accumulation of the X transcript of hepatitis B virus in patients negative for hepatitis B surface antigen with hepatocellular carcinoma.

Authors:  P Paterlini; K Poussin; M Kew; D Franco; C Brechot
Journal:  Hepatology       Date:  1995-02       Impact factor: 17.425

9.  Hepatitis B virus persistence after recovery from acute viral hepatitis.

Authors:  T I Michalak; C Pasquinelli; S Guilhot; F V Chisari
Journal:  J Clin Invest       Date:  1994-01       Impact factor: 14.808

10.  Past exposure to hepatitis B virus as a risk factor for hepatocellular carcinoma in patients with chronic liver disease.

Authors:  S Okada; T Sato; T Okusaka; H Ishii; M Ikeda; H Nakasuka; H Kosakamoto; M Yoshimori; K Wakabayashi
Journal:  Br J Cancer       Date:  1998-06       Impact factor: 7.640

View more
  4 in total

1.  Epidemiology and carcinogenesis of hepatocellular carcinoma.

Authors:  Trishe Y-M Leong; Anthony S-Y Leong
Journal:  HPB (Oxford)       Date:  2005       Impact factor: 3.647

2.  Hepatocellular carcinoma in patients with chronic hepatitis C virus infection without cirrhosis.

Authors:  Kathryn L Nash; Tracy Woodall; Ashley S M Brown; Susan E Davies; Graeme J M Alexander
Journal:  World J Gastroenterol       Date:  2010-08-28       Impact factor: 5.742

3.  Study of transactivating effect of pre-S2 protein of hepatitis B virus and cloning of genes transactivated by pre-S2 protein with suppression subtractive hybridization.

Authors:  Dong Ji; Jun Cheng; Guo-Feng Chen; Yan Liu; Lin Wang; Jiang Guo
Journal:  World J Gastroenterol       Date:  2005-09-21       Impact factor: 5.742

4.  Association between hepatitis C and hepatocellular carcinoma.

Authors:  Luis Jesuino de Oliveria Andrade; Argemiro D'Oliveira; Rosangela Carvalho Melo; Emmanuel Conrado De Souza; Carolina Alves Costa Silva; Raymundo Paraná
Journal:  J Glob Infect Dis       Date:  2009-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.